Gloshell
Ingredients

Ingredient Dictionary

METHYLTHIOPHENYL MORPHOLINO ISOBUTANONE

Molecular structure

Definition

US FDA substance register · UNII 722CLJ6H6K · registered name 2-Methyl-4'-(methylthio)-2-morpholinopropiophenone · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Methylthiophenyl Morpholino Isobutanone is the organic compound that conforms to the formula:

Cosmetic roles

Holds powders togetherBINDING

Safety & regulatory references

Banned
ASEAN · European Union · United Kingdom

Source: ASEAN Cosmetic Directive · EU Cosmetics Regulation · MFDS (Korea) cosmetic regulatory information · UK cosmetics regulations (OPSS)

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

EU Cosmetics Regulation, Annex II (prohibited substances), entry 1592

Source: EU prohibited substances (Annex II)

Restriction II/1592

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Names & identifiers

METHYLTHIOPHENYL MORPHOLINO ISOBUTANONEINCI1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]-2-(4-morpholinyl)-Synonym
CAS No.chemical registry number
71868-10-5
EC No.EU chemical inventory number
400-600-6
DTXSIDUS EPA chemical ID
DTXSID8038857
DTXCIDUS EPA compound ID
DTXCID6018857
IUPAC
2-Methyl-1-[4-(methylsulfanyl)phenyl]-2-(morpholin-4-yl)propan-1-one
Molecular formula
C15H21NO2S
Molecular weight
279.4 g/mol

What products actually use it for

What the 18 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Photosensitizers12
  • Processing aids not otherwise specified3
  • Photosensitive agent2
  • Binder1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

8 skin studies and 4 eye studies are on record.

Classed as low7

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 12 studies
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: OECD 404 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: US EPA s 163.81-5 "Primary dermal irritation study". Federal Register, Vol. 43, No. 163, August 22, 1978. according to
  • Classification not possible
    Skin Irritation · Screening
  • Not likely to be sensitizing
    skin sensitisation · Screening · according to other guideline: 79/831/EEC, Annex V, part B.417 (maximisation test)
  • Not likely to be sensitizing
    skin sensitisation · Screening · according to other guideline: 79/831/EEC, Annex V, part B. 417 (maximisation test)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) modified
  • Classification not possible
    Skin Sensitization · Screening
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: OECD 405 according to
  • Classification not possible
    Eye Irritation · Screening
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: EPA, s 163.81-4 "Primary eye irritation study". Federal Register, Vol. 43, No. 163, August 22, 1978. according to

Source: US EPA CompTox dashboard

Linked databases 16